drugset / Trial / NCT01471717
Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects
RandomizedFactorialQuadruple-blindHealth-services research
Summary
This study is designed to evaluate the potential for a pharmacokinetic drug-drug interaction between INX-08189 and Victrelis, a Direct Acting Antiviral (DAA).
Timeline
- Start
- 2011-10
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986094 | Small molecule | 50 mg | — |
| Comparator | Boceprevir | Small molecule | 800 mg | — |
Indications
No indication recorded.